Insulin therapy in type 2 diabetic subjects suppresses plasminogen activator inhibitor (PAI-1) activity and proinsulin-like molecules independently of glycaemic control - Jain, S K; Nagi, D K; Slavin, B M; Lumb, P J; Yudkin, J S (Diabetic Medicine, 1993)